AmbioPharm is a global peptide CDMO founded in 2005 and headquartered in North Augusta, South Carolina, USA. The company specializes in developing and manufacturing custom peptide APIs for pharmaceutical and biotech companies, with FDA-inspected facilities in the US and China and one of the largest peptide manufacturing capacities in the world.
peptide API manufacturing, solid phase peptide synthesis (SPPS), solution phase synthesis, GMP peptide production, analytical method development, cosmetic peptides, vaccine peptide ingredients
2 sites worldwide
No reviews available yet.
No documents available.